Euretina 2022 Highlights – AMD and Anti VEGFs- By Dr Hamid Riazi
Euretina 2022 Highlights – AMD and Anti VEGFs- By Dr Hamid Riazi
Euretina 2022 Highlights – AMD and Anti VEGFs- By Dr Hamid Riazi
Euretina Highlights -2021
Special Thanks to Dr Hamid Riazi – Dr Nazanin Ebrahimi Adib – Dr Mojtaba Abrishami
Part 1 :
Part 2 :
Journal Club 13-11-2021
Updates on AMD
Special Thanks to Dr Amini And Dr Riazi
Special Thanks to Dr Heidar Abbas
Journal Club 12-12-2020
Special Thanks to Dr M.Hossein Nowroozzadeh and Dr Mohammad Karim Johari and Orchid Pharmed and CinnaGen Company
Journal Club 10-24-2020
How to optimize integration of OCT-Angiography into your daily practice
OCT Angiography (OCTA) is a new, non-invasive, motion contrast microvascular imaging modality that is a user- and patient- friendly addition to the diagnostic armamentarium of more than 650 ophthalmology practices worldwide since its introduction two years ago.
Prof. Bruno Lumbroso and Dr Marco Rispoli (Centro Oftalmologico Meterraneo, Rome, Italy) are worldwide pioneers in the development and adoption of this revolutionary technology. With more than two years of experience using AngioVue OCTA, along with numerous publications and books on the subject, they are recognized as having played a pivotal role in leading both the clinical validation of OCTA, and in defining the OCTA educational standards for the Ophthalmology community.
OCTA is very different from traditional dye-based angiographies, both in terms of image acquisition and interpretation. The aim of this webinar is to provide insight about diagnosing and following AMD patients using OCT Angiography, and how to successfully integrate OCTA into your own practice.